FDA Import Refusal AEK-0821604-5/20001/1 — Merck & Co. Inc
The FDA refused shipment AEK-0821604-5/20001/1 from Merck & Co. Inc (United States) on Aug 6, 2026. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 6, 2026
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
- Charges
- 75